Exo Iris
Payments companies reported to CMS as associated with Exo Iris. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Exo Iris, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Exo Iris
These are the largest totals companies reported as associated with Exo Iris. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Richard Popp | Palo Alto, CA | Cardiovascular Disease | $59,150.00 |
| Kevin Bergman | Santa Rosa, CA | Family Medicine | $35,000.00 |
| Theodore Koutouzis | Chicago, IL | Emergency Medicine | $16,550.00 |
| Diku Mandavia | West Hollywood, CA | Emergency Medical Services | $8,197.00 |
| Gene Bukhman | Boston, MA | Cardiovascular Disease | $7,000.00 |
| Emily Lovallo | Pittsburgh, PA | Emergency Medicine | $4,250.00 |
| Brandon Boesch | Oakland, CA | Internal Medicine | $4,200.00 |
| Nicholas Nelson | Oakland, CA | Internal Medicine | $3,950.00 |
| Trevor Jensen | San Francisco, CA | Internal Medicine | $3,950.00 |
| Manpreet Malik | Atlanta, GA | Hospitalist | $3,582.98 |
Prescribed Exo Iris?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.